CGNT
Cognyte Software Ltd.
CGNT's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CGNT overall, supported by stronger valuation and stronger modeled upside.
CGNT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Strong |
CGNT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CGNT PE Valuation
CGNT has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
CGNT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
CGNT has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CGNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.70 | — |
| Q3 2026 | -$0.00 | +$0.06 |
| Q2 2026 | -$0.04 | +$0.07 |
| Q1 2026 | -$0.01 | +$0.16 |
| Q4 2025 | -$0.08 | +$0.11 |
| Q3 2025 | -$0.06 | $0.00 |
| Q2 2025 | -$0.11 | +$0.06 |
| Q1 2025 | -$0.17 | +$0.03 |
| Q4 2024 | -$0.19 | +$0.38 |
CGNT lost $0.00 per share over the past year, a smaller loss than the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CGNT on earnings, with more consistent year-over-year improvement.
CGNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $109.2M | +12% |
| Q2 2026 | $105.5M | +10% |
| Q1 2026 | $106.2M | +12% |
| Q4 2025 | $100.7M | +13% |
| Q3 2025 | $97.5M | +16% |
| Q2 2025 | $95.5M | +16% |
| Q1 2025 | $94.5M | +13% |
| Q4 2024 | $89M | +12% |
CGNT's revenue has grown year over year for 12 quarters in a row: $109M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.3% | +1.4 points |
| Q2 2026 | 4.2% | +1.9 points |
| Q1 2026 | 4.9% | +4.1 points |
| Q4 2025 | 3.2% | +5.6 points |
| Q3 2025 | 2.8% | +4.5 points |
| Q2 2025 | 2.3% | +5 points |
| Q1 2025 | 0.7% | +4.5 points |
| Q4 2024 | -2.4% | +1.1 points |
CGNT's operating margin was 4.3% last quarter, up 1.4 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CGNT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CGNT on profitability, with a higher operating margin.
CGNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.5M | +$7.4M |
| Q2 2026 | -$6.1M | -$3.7M |
| Q1 2026 | $19.2M | +33% |
| Q4 2025 | $22.8M | +199% |
| Q3 2025 | -$8.9M | -$836K |
| Q2 2025 | -$2.5M | -113% |
| Q1 2025 | $14.4M | +106% |
| Q4 2024 | $7.6M | +$9.9M |
CGNT usually generates cash, though not every quarter: the latest was −$1M, but it generated $34M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CGNT on cash flow, with more consistent year-over-year improvement.
CGNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -1.4% | -1.1M shares |
| 3 years | +4.2% | +2.9M shares |
| 5 years | +10% | +6.7M shares |
| Available history | +11% | +7.4M shares |
CGNT has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.2M |
| Q2 2026 | $8.2M |
| Q1 2026 | $6.2M |
| Q4 2025 | $1.3M |
| Q3 2025 | $5.8M |
| Q2 2025 | $9M |
| Q1 2025 | $5.3M |
| Q4 2024 | — |
CGNT spent $21M buying back its own shares over the past year, up 4.2% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CGNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.7x | Net Cash |
| Q2 2026 | -3.3x | Net Cash |
| Q1 2026 | -3.1x | Net Cash |
| Q4 2025 | -3.6x | Net Cash |
| Q3 2025 | -3.3x | Net Cash |
| Q2 2025 | -4.8x | Net Cash |
| Q1 2025 | -8.2x | Net Cash |
| Q4 2024 | -147.5x | Net Cash |
CGNT has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CGNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 29.4 | Neutral |
CGNT's weekly RSI is 47 (neutral) and its Stochastic is 29 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CGNT PE vs Technology Sector
| Metric | CGNT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CGNT has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CGNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.80 | 4.8% below |
| 20 week MA | $8.74 | 4.1% below |
| 50 week MA | $8.83 | 5.1% below |
| 100 week MA | $8.94 | 6.3% below |
| 200 week MA | $7.46 | 12% above |
CGNT has fallen below most of its moving averages, though it's still 12% above its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CGNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $28.8 | $14.9 | -48% |
| 2022 | $14.9 | $2.75 | -82% |
| 2023 | $2.75 | $6.43 | +134% |
| 2024 | $6.43 | $8.77 | +36% |
| 2025 | $8.77 | $9.31 | +6.2% |
| 2026 YTD | $9.31 | $8.38 | -10% |
CGNT has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.